Leap Therapeutics Inc. (LPTX)
undefined
undefined%
At close: undefined
3.01
1.51%
After-hours Dec 13, 2024, 04:01 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue - - 1.50M 1.50M - - - - - - - -
Cost of Revenue 427.00K 415.00K - - 776.00K 49.00K 48.00K 25.00K - - - -
Gross Profit -427.00K -415.00K 1.50M 1.50M -776.00K -49.00K -48.00K -25.00K - - - -
Operating Income -87.04M -56.76M -41.43M -28.54M -33.45M -30.75M -32.35M -27.52M -21.09M -20.92M -13.87M -8.80M
Interest Income 4.03M 925.00K 9.00K 93.00K 313.00K 447.00K 170.00K 2.00K 156.00K 40.00K 94.00K 102.00K
Pretax Income -81.41M -54.45M -40.61M -27.52M -32.90M -23.12M -29.88M -25.63M -20.95M -25.42M -18.18M -7.76M
Net Income -81.41M -54.60M -40.59M -27.51M -32.90M -23.14M -29.73M -25.63M -21.10M -25.45M -18.32M -7.76M
Selling & General & Admin 13.38M 11.80M 10.77M 9.62M 9.09M 8.92M 9.85M 4.23M 5.72M 4.71M 4.57M 1.51M
Research & Development 73.23M 44.97M 32.16M 20.42M 24.37M 21.07M 22.50M 23.29M 15.37M 15.54M 9.30M 7.17M
Other Expenses - -2.05M -1.23M -231.00K -132.00K 756.00K - 3.12M - - - -
Operating Expenses 87.04M 54.71M 41.70M 29.81M 33.32M 30.00M 32.35M 27.52M 21.09M 20.25M 13.87M 8.68M
Interest Expense - 54.00K 41.00K 39.00K 23.00K 19.00K 121.00K 1.23M 18.00K 4.37M - -
Selling & Marketing Expenses -427.00K - - - - - - - - - - -
Cost & Expenses 87.04M 54.71M 41.70M 29.81M 33.32M 30.00M 32.35M 27.52M 21.09M 20.25M 13.87M 8.68M
Income Tax - 147.00K -24.00K -2.00K -3.00K 20.00K -157.00K 4.35M 152.00K 31.00K 149.00K -
Shares Outstanding (Basic) 20.45M 11.32M 8.58M 5.93M 2.26M 1.41M 916.18K 939.24K 1.71M 1.19M 744.40K 744.40K
Shares Outstanding (Diluted) 20.45M 11.32M 8.58M 5.93M 2.26M 1.44M 918.86K 939.24K 1.71M 1.19M 744.40K 744.40K
EPS (Basic) -3.98 -4.82 -4.73 -4.64 -14.57 -16.36 -32.45 -27.29 -12.37 -21.45 -24.62 -10.42
EPS (Diluted) -3.98 -4.82 -4.73 -4.64 -14.57 -16.05 -32.35 -27.29 -12.37 -21.45 -24.62 -10.42
EBITDA -80.99M -53.98M -40.01M -26.81M -32.10M -23.05M -29.71M -24.37M -11.92M -19.73M -13.23M -6.98M
Depreciation & Amortization 427.00K 415.00K 556.00K 668.00K 776.00K 49.00K 48.00K 25.00K 474.00K 657.00K 640.00K 649.00K